Listed

Phio Pharmaceuticals Corp.

PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31

Reports and events: 316 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phio Pharmaceuticals Corp., Reports and events
FiledFormWhat it isAccession number
2018-03-2616:38 ET10-Q/AQuarterly report, amendedPeriod 2017-06-300001193125-18-096008
2018-03-2616:34 ET10-Q/AQuarterly report, amendedPeriod 2017-03-310001193125-18-095994
2018-03-2616:31 ET8-K4.02 Non-reliance on financial statements0001193125-18-095984
2018-01-2414:31 ET8-K8.01 Other events0001193125-18-018275
2018-01-0517:21 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-004623
2017-11-0807:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-336455
2017-11-0807:01 ET10-QQuarterly reportPeriod 2017-09-300001193125-17-336446
2017-09-1516:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-17-286393
2017-08-1817:22 ETS-1Registration statement0001193125-17-262349
2017-08-1007:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-253563
2017-08-1007:06 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-253552
2017-08-0907:38 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-17-252087
2017-08-0308:06 ET8-K3.01 Delisting notice0001193125-17-246784
2017-07-3117:29 ETS-1/ARegistration statement, amended0001193125-17-242561
2017-07-1417:16 ETS-1Registration statement0001193125-17-228636
2017-06-0917:20 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-17-200237
2017-05-1107:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-166579
2017-05-1107:01 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-166563
2017-05-0107:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-150170
2017-04-2716:31 ETDEF 14AProxy statementPeriod 2017-06-060001193125-17-143109
2017-04-1816:37 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-17-127431
2017-03-3007:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-102782
2017-03-3007:01 ET10-KAnnual reportPeriod 2016-12-310001193125-17-102730
2017-03-2913:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-101354
2017-03-2811:51 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-099178
2017-02-0317:25 ET8-K3.01 Delisting notice0001193125-17-030905
2017-01-1017:21 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-17-006979
2016-12-2116:35 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-800538
2016-12-1920:57 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-796199
2016-12-1509:06 ETS-1/ARegistration statement, amended0001193125-16-793785
2016-12-1413:58 ETS-1/ARegistration statement, amended0001193125-16-792793
2016-11-3021:51 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-779955
2016-11-3021:49 ETS-1/ARegistration statement, amended0001193125-16-779953
2016-11-1421:20 ETS-1/ARegistration statement, amended0001193125-16-766243
2016-11-1007:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-765112
2016-11-1007:01 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-765096
2016-11-0416:33 ETDEF 14AProxy statementPeriod 2016-12-150001193125-16-760234
2016-10-2117:19 ETS-1Registration statement0001193125-16-743993
2016-10-1207:11 ET8-K8.01 Other events0001193125-16-736264
2016-08-1107:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-678589
2016-08-1107:01 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-678578
2016-05-1207:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-588044
2016-05-1207:01 ET10-QQuarterly reportPeriod 2016-03-310001193125-16-588016
2016-05-0416:30 ET8-K8.01 Other events0001193125-16-577701
2016-04-1514:25 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-542971
2016-03-3016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-523746
2016-03-3016:08 ET10-KAnnual reportPeriod 2015-12-310001193125-16-523721
2016-03-0717:20 ETDEF 14AProxy statementPeriod 2016-04-140001193125-16-495425
2015-11-1216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-15-375658
2015-11-1216:05 ET10-QQuarterly reportPeriod 2015-09-300001193125-15-375630

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.